Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The catheter market was valued at USD 62.12 Billion in 2025. It is poised to grow at a CAGR of 6.60% during the forecast period of 2026-2035, and reach USD 117.71 Billion by 2035. The market growth is driven by the rising global burden of cardiovascular disease, expanding adoption of pulsed field ablation, growing demand for minimally invasive vascular access, and accelerating innovation in robotic and neurovascular catheter platforms.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
6.6%
Value in USD Billion
2026-2035
*this image is indicative*
Catheters play a critical role in modern healthcare by supporting minimally invasive procedures, fluid management, cardiovascular interventions, and urinary care across hospitals and ambulatory settings. The market is poised to reach USD 117.71 Billion by 2035, supported by rising cardiovascular and neurovascular procedure volumes, growing chronic disease prevalence, and broadening clinical indications for minimally invasive interventions. The accelerating shift toward pulsed field ablation, robotic navigation, and lower-profile access catheters is enhancing procedural safety and efficiency. Continued integration with cardiovascular devices platforms and EP mapping systems is further reinforcing the role of advanced catheters across modern interventional cardiology and electrophysiology suites.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Product
The market is segmented by product into vascular catheters, neurovascular catheters, urology catheters, intravenous catheters, and specialty catheters, with rising demand supported by increasing cardiovascular interventions, growing prevalence of atrial fibrillation, and expanding use of minimally invasive catheter-based diagnostic and therapeutic procedures.
Market Breakup by Lumen Type
The market is categorized by lumen type into single-lumen catheters, double-lumen catheters, triple-lumen catheters, and others, driven by the growing adoption of advanced medical devices for efficient fluid administration, dialysis access, critical care monitoring, and multi-channel therapeutic delivery applications.
Market Breakup by End User
The market is divided by end user into hospitals, ambulatory surgical centers, and others, supported by increasing patient admissions, expanding surgical volumes, improving emergency care infrastructure, and rising preference for specialized catheterization procedures across modern healthcare facilities.
Market Breakup by Region
The market is segmented by region into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate due to advanced healthcare infrastructure, rapid adoption of innovative catheter platforms, and strong reimbursement coverage, while Asia Pacific is anticipated to expand rapidly, supported by rising cardiovascular disease burden and improving access to interventional cardiology procedures across China, Japan, and India.
|
Analysis Type |
Factors |
Example |
|
Market Drivers |
Rising cardiovascular disease burden and expanding electrophysiology procedure volumes |
According to the World Health Organization, cardiovascular diseases cause approximately 17.9 million deaths annually, accelerating electrophysiology catheter adoption. |
|
Market Restraints |
Increasing Catheter-associated infection risks and stringent reimbursement controls |
According to WHO, nearly 75% of hospital-acquired urinary tract infections are linked to urinary catheter usage globally. |
|
Market Opportunities |
Expansion of robotic catheter navigation and neurovascular innovation creating strong growth opportunities in minimally invasive cardiac procedures. |
In January 2026, the FDA approved Stereotaxis’s MAGiC magnetic ablation catheter for complex congenital heart disease treatment applications. |
This section analyzes key factors influencing market growth, including disease burden, regulatory drivers, technology adoption, cost dynamics, and ecosystem shifts.
Rising Cardiovascular Disease Burden and EP Procedure Volumes Driving Market Value
The market is witnessing strong growth driven by the rising global burden of cardiovascular disease and the rapidly expanding volumes of electrophysiology devices across the cardiac arrhythmia segment. According to the World Health Organization, cardiovascular diseases remain the leading cause of death globally, claiming an estimated 17.9 million lives each year. The increasing prevalence is accelerating the adoption of advanced electrophysiology mapping systems, cardiac ablation catheters, and implantable monitoring devices. In addition, continuous technological advancements in minimally invasive cardiac procedures and real-time diagnostic capabilities are further supporting market expansion across hospitals and specialty cardiac centers.
Rising Catheter-Associated Infections Limiting the Market Growth
The increasing prevalence of catheter-associated infections and related complications is a significant factor limiting the growth of the catheter market. Prolonged catheter use can increase the risk of urinary tract infections, bloodstream infections, thrombosis, and extended hospital stays, creating concerns regarding patient safety and treatment costs. According to the World Health Organization (WHO), Catheter-Associated Urinary Tract Infections (CAUTIs) are among the most common healthcare-associated infections, with nearly 75% of hospital-acquired urinary tract infections linked to urinary catheters. The growing burden of such complications is leading to stricter infection control protocols and cautious adoption of catheter devices across healthcare facilities.
Robotic Navigation and Neurovascular Innovation Creating Strong Opportunities
The expansion of robotic catheter navigation and the growing pipeline of next-generation neurovascular access devices are creating significant growth opportunities, supported by improved procedural precision and broader patient eligibility. For instance, in January 2026, the FDA approved Stereotaxis's MAGiC magnetic ablation catheter, the first ablation catheter cleared specifically for supraventricular tachycardia in patients with complex congenital heart disease. These developments are accelerating the adoption of robotic platforms and reinforcing the role of advanced catheters across the interventional cardiology and neurointerventional segments.
Pulsed Field Ablation and Lower-Profile Access Shaping Market Evolution
The growing emphasis on pulsed field ablation (PFA) and lower-profile neurovascular access catheters is a key trend shaping the market, supported by improved tissue selectivity in PFA and expanded radial-access workflows in stroke care. For instance, in April 2026, Radical Catheter Technologies received FDA 510(k) clearance for its 6F neurovascular access catheter, expanding therapeutic options across radial-access middle-meningeal artery embolization procedures. These innovations are reshaping the growth across the market.
Cardiovascular Catheters Likely to Dominate the Market Segment by Product Type
Among all the product type, the vascular catheters segment is likely to lead the market, due to the growing prevalence of cardiovascular diseases and the increasing number of minimally invasive diagnostic and interventional procedures worldwide. The segment is also benefiting from continuous advancements in catheter design, including enhanced flexibility, infection resistance, and navigation capabilities. Increasing hospital admissions related to cardiac disorders and expanding adoption of image-guided vascular procedures are further supporting segment growth. The rising focus on improving patient outcomes and procedural efficiency is expected to sustain demand for vascular catheters during the forecast period.
Among all the regions, North America is expected to witness significant growth in the market, holding about 29% of the share in the historical period, supported by advanced healthcare infrastructure, rapid adoption of pulsed field ablation and robotic catheter platforms, and strong reimbursement coverage for interventional procedures. The region benefits from a high concentration of FDA approvals for catheter innovations and the presence of leading manufacturers, along with well-established electrophysiology networks that reinforce steady market growth during the forecast period.
Abbott Laboratories is a global healthcare company involved in the catheter market through its advanced cardiovascular portfolio. The company offers CPS Locator 3D Catheters and CPS Aim Universal II catheters designed for coronary sinus cannulation, left ventricular lead delivery, and cardiac positioning procedures. These products support electrophysiology and cardiac rhythm management applications, strengthening its presence in the global catheter market.
Coloplast A/S, headquartered in Humlebaek, Denmark, was founded in 1957 and develops products and services for ostomy care, urology, continence care, and wound and skin care. Its catheter portfolio includes the SpeediCath intermittent catheter family and Mentor urology catheter solutions, reinforcing its strong position in the urological and continence care segments.
Hollister Incorporated, headquartered in Libertyville, Illinois, United States, was founded in 1921 and is an employee-owned medical device company specializing in continence care, ostomy care, and critical care. Its catheter portfolio includes the VaPro and Advance Plus intermittent catheter ranges, supporting strong positions in urinary continence and home care segments globally.
Medtronic plc, headquartered in Dublin, Ireland, was founded in 1949 and is a global leader in medical technology spanning cardiovascular, neuroscience, surgical, and diabetes therapies. Its catheter portfolio includes Arctic Front cryoablation, Achieve mapping, and Sphere-9 catheters across electrophysiology and structural heart procedures, alongside vascular access and urology product lines.
Other players in the market are B. Braun Melsungen AG, Boston Scientific Corporation, ConvaTec Inc., Merit Medical Systems, Inc., Johnson and Johnson, and Stryker Corporation.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Lumen Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share